330 Results

People

  1. Scheinberg
    Scheinberg
  2. Levine
    Levine
  3. Tallman
    Tallman
  4. Abdel-Wahab
    Abdel-Wahab
  5. Brentjens
    Brentjens
  6. Mcdevitt
    Mcdevitt
  7. Klimek
    Klimek
  8. Rampal
    Rampal
  9. Berman
    Berman
  10. Dao
    Dao

Groups

  1. Adult Leukemia (330)
  2. Center for Hematologic Malignancies (330)
  3. Department of Medicine (327)
  4. Hematologic Malignancies, Division of (327)
  5. GSK Faculty (200)
  6. Tow Center for Developmental Oncology (TCDO) (129)
  7. Sloan Kettering Institute Faculty (128)
  8. Hematologic Malignancies Research (125)
  9. Molecular Pharmacology and Chemistry Program Faculty (115)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (99)
  1. "controlled study"
  2. "Adult Leukemia"
Formats
  1. Journal Article (313)
  2. Research Letter (13)
  3. Conference Paper (2)
  4. Correspondence (1)
  5. Review (1)
Groups
  1. Adult Leukemia (330)
  2. Center for Hematologic Malignancies (330)
  3. Department of Medicine (327)
  4. Hematologic Malignancies, Division of (327)
  5. GSK Faculty (200)
  6. Tow Center for Developmental Oncology (TCDO) (129)

More Groups

People
  1. David Scheinberg (88)
  2. Ross Levine (75)
  3. Martin Tallman (62)
  4. Omar Abdel-Wahab (28)
  5. Renier Brentjens (23)
  6. Michael Mcdevitt (22)

More People

Years
  1. 2024 (9)
  2. 2023 (28)
  3. 2022 (16)
  4. 2021 (10)
  5. 2020 (18)
  6. 2019 (20)

More Years

Publications
  1. Blood (49)
  2. Leukemia (35)
  3. Clinical Cancer Research (19)
  4. Blood Advances (13)
  5. Leukemia Research (10)
  6. Cancer Research (9)

More Publications

Publishers
  1. Nature Publishing Group (69)
  2. American Society of Hematology (62)
  3. American Association for Cancer Research (34)
  4. Cell Press (15)
  5. Elsevier Inc. (13)
  6. Elsevier Ltd (10)

More Publishers

Results (330)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: A phase II clinical trial
    Research Letter

    Bewersdorf, J. P.; Stahl, M.; Taylor, J.; Mi, X.; Chandhok, N. S.; Watts, J.; Derkach, A.; Wysocki, M.; Lu, S. X.; Bourcier, J.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications
    Journal Article

    Kurtz, K.; Eibler, L.; Dacek, M. M.; Carter, L. M.; Veach, D. R.; Lovibond, S.; Reynaud, E.; Qureshy, S.; McDevitt, M. R.; Bourne, C.; more...
    Theranostics (2023)

    Fulltext@MSK | Save
  • Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
    Journal Article

    Ptashkin, R. N.; Ewalt, M. D.; Jayakumaran, G.; Kiecka, I.; Bowman, A. S.; Yao, J. J.; Casanova, J.; Lin, Y. T. D.; Petrova-Drus, K.; Mohanty, A. S.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories
    Journal Article

    Borate, U.; Yang, F.; Press, R.; Ruppert, A. S.; Jones, D.; Caruthers, S.; Zhao, W.; Vergilio, J. A.; Pavlick, D. C.; Juckett, L.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1
    Journal Article

    Mun, S. S.; Meyerberg, J.; Peraro, L.; Korontsvit, T.; Gardner, T.; Malviya, M.; Kyi, C.; O’Cearbhaill, R. E.; Liu, C.; Dao, T.; more...
    Cancer Immunology, Immunotherapy (2023)

    Fulltext@MSK | Save
  • The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles
    Journal Article

    Molvi, Z.; Klatt, M. G.; Dao, T.; Urraca, J.; Scheinberg, D. A.; O'Reilly, R. J.
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Clonal hematopoiesis in survivors of childhood cancer
    Research Letter

    Friedman, D. N.; Chan, I. C. C.; Moskowitz, C. S.; Li, S.; Turner, K.; Liu, J.; Bouvier, N.; Walsh, M. F.; Spitzer, B.; Kung, A. L.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia
    Journal Article

    Roeker, L. E.; DerSarkissian, M.; Ryan, K.; Chen, Y.; Duh, M. S.; Wahlstrom, S. K.; Hakre, S.; Yu, L.; Guo, H.; Mato, A. R.
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel
    Review

    Perissinotti, A. J.; Bishop, M. R.; Bubalo, J.; Geyer, M. B.; Goodrich, A.; Howard, S. C.; Kula, J.; Mandayam, S.; Cairo, M. S.; Pui, C. H.
    Cancer Treatment Reviews (2023)

    Fulltext@MSK | Save
  • Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial
    Journal Article

    Duong, V. H.; Ruppert, A. S.; Mims, A. S.; Borate, U.; Stein, E. M.; Baer, M. R.; Stock, W.; Kovacsovics, T.; Blum, W.; Arellano, M. L.; more...
    Cancer (2023)

    Fulltext@MSK | Save